A novel t(7;17)(q11;q11) as the sole karyotypic abnormality in childhood pre-B-cell acute lymphoblastic leukemiaLEE, A. C. W; MA, S. K; WAN, T. S. K et al.Cancer genetics and cytogenetics. 1998, Vol 104, Num 1, pp 70-71, issn 0165-4608Article

A case of Philadelphia-negative, M-BCR rearranged eosinophilic leukaemia with trisomy 8 localized by in situ hybridizationCHAN, L. C; KWONG, Y. L; LIE, A. K. W et al.Leukemia. 1994, Vol 8, Num 1, pp 195-198, issn 0887-6924Article

Cytogenetic abnormalities in pediatric myelodysplastic syndrome : A report of three casesMA, S. K; HA, S. Y; CHAN, G. C. F et al.Cancer genetics and cytogenetics. 1997, Vol 93, Num 2, pp 172-176, issn 0165-4608Article

RT/PCR detection of SIL-TAL-1 fusion mRNA in Chinese T-cell acute lymphoblastic leukemia (T-ALL)WEI HUANG; SHAO-QIN KUANG; QIU-HUA HUANG et al.Cancer genetics and cytogenetics. 1995, Vol 81, Num 1, pp 76-82, issn 0165-4608Article

Complex cytogenetic abnormalities in T-lymphoblastic lymphoma : Resolution by spectral karyotypingWAN, T. S. K; MA, S. K; CHAN, G. C. F et al.Cancer genetics and cytogenetics. 2000, Vol 118, Num 1, pp 24-27, issn 0165-4608Article

Cytogenetics and immunophenotypes of childhood acute lymphoblastic leukemia in Hong KongCHAN, L. C; HA, S. Y; CHING, L. M et al.Cancer genetics and cytogenetics. 1994, Vol 76, Num 2, pp 118-124, issn 0165-4608Article

8;21 translocation and multilineage involvementKWONG, Y. L; CHING, L. M; LIU, H. W et al.American journal of hematology. 1993, Vol 43, Num 3, pp 212-216, issn 0361-8609Article

Acute myeloid leukaemia with giant granules : association with t(10; 11)(p13; q14) and disseminated intravascular coagulationMA, S. K; YIP, S. F; WAN, T. S. K et al.Clinical and laboratory haematology. 2000, Vol 22, Num 5, pp 303-305, issn 0141-9854Article

A novel t(1;10)(q32;p12) in acute myelomonocytic leukemiaWAN, T. S. K; MA, S. K; CHING, L. M et al.Cancer genetics and cytogenetics. 1999, Vol 114, Num 1, pp 85-86, issn 0165-4608Article

Trisomy 12 in chronic lymphocytic leukemia : an interphase cytogenetic study by fluorescence in situ hybridizationKWONG, Y. L; PANG, J; CHING, L. M et al.Cancer genetics and cytogenetics. 1994, Vol 72, Num 2, pp 83-85, issn 0165-4608Article

Cytogenetic analysis of hematologic malignancies in Hong Kong : a study of 98 casesCHAN, L. C; KWONG, Y. L; LIU, H. W et al.Cancer genetics and cytogenetics. 1992, Vol 62, Num 2, pp 154-159, issn 0165-4608Article

Translocation (12;17)(p11-12;q11-12) : a recurrent primary rearrangement in acute leukemiaLIU, H. W; WAN, S. K; CHING, L. M et al.Cancer genetics and cytogenetics. 1992, Vol 64, Num 1, pp 27-29, issn 0165-4608Article

Effect of flavone acetic acid (NSC 347 512) on splenic cytotoxic effector cells and their role in tumour necrosisCHING, L.-M; BAGULEY, B. C.European journal of cancer & clinical oncology. 1989, Vol 25, Num 5, pp 821-828, issn 0277-5379Article

Relationship between tumour endothelial cell apoptosis and tumour blood flow shutdown following treatment with the antivascular agent DMXAA in miceCHING, L-M; ZWAIN, S; BAGULEY, B. C et al.British journal of cancer. 2004, Vol 90, Num 4, pp 906-910, issn 0007-0920, 5 p.Article

The antitumour agent 5,6-dimethylxanthenone-4-acetic acid acts in vitro on human mononuclear cells as a co-stimulator with other inducers of tumour necrosis factorPHILPOTT, M; CHING, L.-M; BAGULEY, B. C et al.European journal of cancer (1990). 2001, Vol 37, Num 15, pp 1930-1937, issn 0959-8049Article

A role for interleukin-6 in spreading endothelial cell activation after phagocytosis of necrotic trophoblastic material : implications for the pathogenesis of pre-eclampsiaCHEN, Q; STONE, P; CHING, L.-M et al.Journal of pathology (Print). 2009, Vol 217, Num 1, pp 122-130, issn 0022-3417, 9 p.Article

The antitumour activity of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF receptor-1 knockout miceZHAO, L; CHING, L.-M; KESTELL, P et al.British journal of cancer. 2002, Vol 87, Num 4, pp 465-470, issn 0007-0920Article

Antitumour responses to flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid in immune deficient miceCHING, L.-M; JOSEPH, W. R; BAGULEY, B. C et al.British journal of cancer. 1992, Vol 66, Num 1, pp 128-130, issn 0007-0920Article

Production of tumour necrosis factor-α by cultured human peripheral blood leucocytes in response to the antitumour agent 5,6-dimethylxanthenone-4-acetic acid (NSC 640488)PHILPOTT, M; JOSEPH, W. R; CROSIER, K. E et al.British journal of cancer. 1997, Vol 76, Num 12, pp 1586-1591, issn 0007-0920Article

Vitamin C Enhances Phagocytosis of Necrotic Trophoblasts by Endothelial Cells and Protects the Phagocytosing Endothelial Cells from ActivationCHEN, Q; JONES, D; STONE, P et al.Placenta (Eastbourne). 2009, Vol 30, Num 2, pp 163-168, issn 0143-4004, 6 p.Article

Induction of STAT and NFKB activation by the antitumor agents 5,6-dimethylxanthenone-4-acetic acid and flavone acetic acid in a murine macrophage cell lineCHING, L.-M; YOUNG, H. A; EBERLY, K et al.Biochemical pharmacology. 1999, Vol 58, Num 7, pp 1173-1181, issn 0006-2952Article

Antitumour activity of the novel immune modulator 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice lacking the interferon-gamma receptorPANG, J.-H; CAO, Z; JOSEPH, W. R et al.European journal of cancer (1990). 1998, Vol 34, Num 8, pp 1282-1289, issn 0959-8049Article

Modulation of the pharmacokinetics of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice by thalidomideKESTELL, P; LIANGLI ZHAO; BAGULEY, B. C et al.Cancer chemotherapy and pharmacology. 2000, Vol 46, Num 2, pp 135-141, issn 0344-5704Article

Interaction of thalidomide, phthalimide analogues of thalidomide and pentoxifylline with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid : concomitant reduction of serum tumour necrosis factor-alpha and enhancement of anti-tumour activityCHING, L.-M; BROWNE, W. L; TCHERNEGOVSKI, R et al.British journal of cancer. 1998, Vol 78, Num 3, pp 336-343, issn 0007-0920Article

Suppression of serum tumour necrosis factor-α by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acidBROWNE, W. L; WILSON, W. R; BAGULEY, B. C et al.Anticancer research. 1998, Vol 18, Num 6A, pp 4409-4413, issn 0250-7005Conference Paper